CONVERTIBLE NOTE

articles with this tag

We are Rolling the Dice on this One…

We are Rolling the Dice on this One…

Long term Creso Pharma (ASX: CPH) shareholders have had a rough ride in the last 12 months. Last week the $20M capped CPH raised circa A$9M at $0.0291 per share, finally extinguishing the company’s debt and ridding the company of major con note holders that were hampering any share price appreciation.

Thanks for subscribing!

X